|
"Alpha Particle-emitting Erb-2 Tumor-targeting Peptides" - Topic 255
|
N43CO900062-000
|
$150,000
|
$37,500
|
Testa, Richard
|
ALPHAMED INC:1120333
|
|
"Statistical Methods for Genetic Epidemiology"
|
5R01CA094069-08
|
$573,074
|
$189,114
|
Whittemore, Alice
|
STANFORD UNIVERSITY
|
|
A Computational Platform for Analyzing and Visualizing Integrated TCGA Data in th
|
5R21CA135870-02
|
$142,200
|
$46,926
|
SANDER, CHRIS
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
A Low-Dose Decitabine Strategy for Restoring Ovarian Cancer Sensitivity
|
5R21CA133877-02
|
$341,244
|
$341,244
|
Matei, Daniela
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
A nanoparticle prognosticator of chemotherapy outcomes
|
1R43CA141747-01
|
$139,513
|
$139,513
|
LEBOVITZ, RUSSELL
|
MARVAL BIOSCIENCES, INC.
|
|
A near-infrared contrast agent for targeted imaging of cancer
|
5K25CA120350-03
|
$137,959
|
$137,959
|
Romanowski, Marek
|
UNIVERSITY OF ARIZONA
|
|
A POLYMERIC DRUG DELIVERY SYSTEM FOR CANCER THERAPY
|
5R01CA051578-17
|
$236,153
|
$236,153
|
KOPECEK, JINDRICH
|
UNIVERSITY OF UTAH
|
|
A Pooled Analysis to Identify New Ovarian Cancer Risk Factors
|
1R01CA136891-01A1
|
$350,489
|
$350,489
|
PEARCE, CELESTE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
A Spatial-Spectral Volume Holographic Imaging System for Ex-Vivo and In-Vivo Canc
|
1R01CA134424-01A1
|
$429,050
|
$429,050
|
KOSTUK, RAYMOND
|
UNIVERSITY OF ARIZONA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S1
|
$114,606
|
$2,819
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S3
|
$100,000
|
$2,460
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-34
|
$7,326,647
|
$180,236
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Academic-industrial partnership for development of in vivo imaging systems and me
|
5R01CA133148-02
|
$462,824
|
$115,706
|
XU, CHRIS
|
CORNELL UNIVERSITY ITHACA
|
|
Adaptive Immunity from High Affinity Anti-HER2/neu Monoclonal Antibodies
|
5R01CA121033-04
|
$261,149
|
$261,149
|
WEINER, LOUIS
|
GEORGETOWN UNIVERSITY
|
|
ADD ARTICLE H.49., EXCHANGE OF CONFIDENTIAL INFORMATION AND RESEARCH MATERIALS
|
N01CO800001-012
|
$231,187,932
|
$692,000
|
ARTHUR, LARRY
|
SAIC-FREDERICK INC:1107088
|
|
Affinity-based Seurm Proteomics: Breast/Ovarian Cancer
|
5U01CA111273-05
|
$543,158
|
$271,579
|
MCINTOSH, MARTIN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
American College of Radiology Imaging Network
|
5U01CA080098-11
|
$8,896,390
|
$444,820
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
An Integrative Genomics Data Viewer to Support the TCGA Project
|
5R21CA135827-03
|
$205,500
|
$67,815
|
MESIROV, JILL
|
BROAD INSTITUTE, INC.
|
|
Analysis of BRCA1 Function in DNA Repair
|
7R01CA089239-11
|
$179,718
|
$89,859
|
CHEN, JUNJIE
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Analysis of BRCA1 Function in DNA Repair
|
5R01CA089239-10
|
$70,605
|
$35,303
|
CHEN, JUNJIE
|
YALE UNIVERSITY
|
|
Analysis of BRCA1 recombination functions
|
2R01CA095175-06A1
|
$304,354
|
$152,177
|
SCULLY, RALPH
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Analysis of Human Immune Reponses in Cancer Vaccine Clinical Trials
|
ZIA BC 010425
|
$396,900
|
$39,690
|
Schlom, Jeffrey
|
CCR (NCI)
|
|
Antiangiogenic Gene Therapy of Ovarian and Breast Cancers
|
5R01CA114340-03
|
$253,350
|
$126,675
|
RAMAKRISHNAN, SUNDARAM
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Antibody Therapy of Cancer
|
ZIA BC 010891
|
$487,301
|
$146,190
|
Ho, Mitchell
|
CCR (NCI)
|
|
Apoptotic regulators in ovarian cancer
|
5R01CA118678-03
|
$314,450
|
$314,450
|
MOR, GIL
|
YALE UNIVERSITY
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
2P30CA023074-31
|
$4,161,907
|
$1,123,715
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-31S1
|
$105,806
|
$28,568
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Autocrine Wnt signaling in human breast and ovarian cancer cells
|
7R01CA121119-03
|
$205,200
|
$102,600
|
Bafico, Anna
|
CARDIFF UNIVERSITY
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S1
|
$117,279
|
$10,555
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S2
|
$245,600
|
$22,104
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-03
|
$1,515,000
|
$136,350
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-08
|
$749,588
|
$29,984
|
DECKER, DAVID
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Biobehavioral Influences and the Ovarian Tumor Microenvironment
|
1R01CA140933-01
|
$599,954
|
$599,954
|
LUTGENDORF, SUSAN
|
UNIVERSITY OF IOWA
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$728,095
|
$72,809
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biomarker Detection Using NAPPA Tumor Antigen Arrays
|
7U01CA117374-05
|
$440,121
|
$110,030
|
LABAER, JOSHUA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Biomarker Reference Laboratory, EDRN
|
5U24CA086359-10
|
$446,996
|
$44,700
|
GRIZZLE, WILLIAM
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
BIOMARKER SCREENING WITH REVOLUTIONARY NEOABS
|
N44CN733001-004
|
$35,615
|
$35,615
|
MULLER, UWE
|
NEOCLONE BIOTECHNOLOGY:1120390
|
|
Biomarkers with Biological Function in Ovarian Carcinoma
|
5R01CA106878-05
|
$274,365
|
$274,365
|
SKUBITZ, AMY
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Boosting anti-tumor immune responses by modulating genes with nanoparticles
|
1R21CA132026-01A1
|
$179,782
|
$179,782
|
Conejo-Garcia, Jose
|
DARTMOUTH COLLEGE
|
|
Boosting therapeutic immunity against Ovarian Cancer through CD40/TLR agonists
|
1F31CA134188-01A1
|
$41,176
|
$41,176
|
Scarlett, Uciane
|
DARTMOUTH COLLEGE
|
|
BRCA1 Function in Post-Damage Nuclear Foci
|
1R01CA136512-01A1
|
$443,843
|
$110,961
|
LIVINGSTON, DAVID
|
DANA-FARBER CANCER INSTITUTE
|
|
BRCA2 Hereditary Ovarian Cancer Tissue Truncation Test
|
2R42CA124191-02A1
|
$299,203
|
$299,203
|
HOLT, JEFFREY
|
TISSUE GENETICS, INC.
|
|
Breast imaging studies in women at high genetic risk of breast cancer
|
ZIA CP010145-07040
|
$659,548
|
$98,932
|
Greene
|
DCEG (NCI)
|
|
Breast, ovarian and endometrial cancer in Polish women
|
ZIA CP010126-01033
|
$1,157,782
|
$173,667
|
Closas, Garcia
|
DCEG (NCI)
|
|
Bridging Geographic Barriers: Remote Cancer Genetics Counseling for Rural Women
|
1R01CA129142-01A2
|
$637,818
|
$318,909
|
KINNEY, ANITA
|
UNIVERSITY OF UTAH
|
|
BRIT 1: Roles in Immortalization, Checkpoints and Cancer
|
5R01CA112291-05
|
$252,809
|
$126,405
|
LIN, SHIAW-YIH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,313,626
|
$131,363
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Cancer Center Support
|
3P30CA047904-21S2
|
$5,021,590
|
$200,864
|
DAVIDSON, NANCY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-38
|
$2,844,058
|
$28,441
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-34S1
|
$113,210
|
$10,189
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
Total relevant funding to Ovarian Cancer for this search: $110,121,501
|